NMDP BIOTHERAPIES
LIVE

Serial Number

98152034

Owner

National Marrow Donor Program

Attorney

Kourtney A. Mulcahy

Filing Date

Aug 26, 2023

Add to watchlist:

No watchlists yet
View on USPTO

NMDP BIOTHERAPIES Trademark

Serial Number: 98152034 • Registration: 8170229

NMDP BIOTHERAPIES is a trademark filed by National Marrow Donor Program on August 26, 2023. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

National Marrow Donor Program (80 trademarks)

500 N 5th St.
Minneapolis, MN 554011206

Entity Type: 99

Trademark Details

Filing Date

August 26, 2023

Registration Date

March 10, 2026

Published for Opposition

February 6, 2024

Goods & Services

Biological tissue, namely, bone marrow and peripheral blood stem cells of consented donors of bone marrow and blood stem cells for medical purposes

Biological tissue, namely, bone marrow and peripheral blood stem cells of consented donors of bone marrow and blood stem cells for scientific research use, namely, for developing new cellular therapies and other treatments

educational and training services, namely, providing seminars, workshops, conferences, classes, lectures and presentations in the field of stem cells, stem cell research and stem cell applications and cellular therapies and distribution of course and educational materials in connection therewith

Logistics management in the medical field, namely, management and coordination of medical services related to bone marrow and stem cell donation; Transportation logistics services, namely, arranging for the transportation of goods for others, particularly of products and samples from a collection site to entities who are developing new cellular therapies and other treatments related to bone marrow and peripheral blood stem cells

providing medical research services for developing new cellular therapies and other treatments in the field of bone marrow and peripheral blood stem cells

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Mar 10, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Mar 10, 2026 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Feb 19, 2026 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Feb 19, 2026 CNPR
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 19, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 19, 2026 CRFA
ASSIGNED TO LIE
Feb 19, 2026 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 10, 2026 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Nov 7, 2025 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Nov 7, 2025 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 11, 2025 GNRN
NON-FINAL ACTION E-MAILED
Aug 11, 2025 GNRT
SU - NON-FINAL ACTION - WRITTEN
Aug 11, 2025 CNRT
STATEMENT OF USE PROCESSING COMPLETE
Jun 28, 2025 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jun 28, 2025 AITU
USE AMENDMENT FILED
Mar 26, 2025 IUAF
TEAS STATEMENT OF USE RECEIVED
Mar 26, 2025 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 2, 2024 EXRA
SOU EXTENSION 1 GRANTED
Oct 2, 2024 EX1G
SOU EXTENSION 1 FILED
Oct 2, 2024 EXT1
SOU TEAS EXTENSION RECEIVED
Oct 2, 2024 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Apr 2, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 6, 2024 NPUB
PUBLISHED FOR OPPOSITION
Feb 6, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 17, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 28, 2023 CNSA
EXAMINER'S AMENDMENT ENTERED
Dec 28, 2023 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Dec 28, 2023 GNEN
EXAMINERS AMENDMENT E-MAILED
Dec 28, 2023 GNEA
EXAMINERS AMENDMENT -WRITTEN
Dec 28, 2023 CNEA
ASSIGNED TO EXAMINER
Dec 26, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 26, 2023 NWOS
NEW APPLICATION ENTERED
Aug 30, 2023 NWAP